Exact Sciences
EXAS
#1187
Rank
A$27.91 B
Marketcap
A$147.00
Share price
0.51%
Change (1 day)
70.12%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -A$1.56 Billion

According to Exact Sciences's latest financial reports the company's current earnings are A$3.08 Billion. In 2024 the company made an earning of -A$1.45 Billion a decrease over its 2023 earnings that were of -A$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$1.56 Billion7.7%
2024 -A$1.45 Billion435.05%
2023 -A$0.28 Billion-69.18%
2022 -A$0.88 Billion-25.77%
2021 -A$1.19 Billion1.68%
2020 -A$1.17 Billion271.17%
2019 -A$0.32 Billion58.99%
2018 -A$0.2 Billion20.89%
2017 -A$0.17 Billion-30.95%
2016 -A$0.24 Billion5.09%
2015 -A$0.23 Billion57.24%
2014 -A$0.15 Billion116.53%
2013 -A$65.96 Million
2011 -A$41.07 Million143.73%
2010 -A$16.85 Million27.85%
2009 -A$13.18 Million0.27%
2008 -A$13.15 Million-20.95%
2007 -A$16.63 Million-13.53%
2006 -A$19.23 Million-10.07%
2005 -A$21.39 Million-21.81%
2004 -A$27.35 Million-33.44%
2003 -A$41.09 Million-6.51%
2002 -A$43.95 Million17.95%
2001 -A$37.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
A$12.96 B-1,038.16%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
A$35.25 M-102.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
A$93.86 M-106.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-A$0.6 Billion-56.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-A$49.82 Million-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA